March 19, 2013
Contact: Mike Barra (mbarra@ralandcorp.com)
Direct Phone: 585-598-1180 ext. 740
CHARLESTON, SC – Efferent Labs®, a vanguard in biotechnological innovation, today announced a
(BUFFALO, NY) Apr. 1, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in
(BUFFALO, NY) Feb. 15, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in
Efferent Labs offers a live, cellular data acquisition platform that will radically alter the landscape of pre-clinical research in animals.
Efferent Labs® offers a live, cellular data acquisition platform that will radically alter the landscape of pre-clinical research in animals.
Sign up for email alerts of Press Releases and Efferent Labs’ breaking news
